# Commission Regulation (EC) No 1064/2007 of 17 September 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Avilamycin (Text with EEA relevance), Division 1.2.15

Extent: E+W+S+N.I.

Orthosomycins
For porcine and poultry species, this MRL relates to skin and fat in natural proportions.
Not for use in animals from which eggs are produced for human consumption.
For porcine and poultry species, this MRL relates to skin and fat in natural proportions.
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Avilamycin
Dichloroisoeverninic acid
Porcine
50 μg/kg
Muscle
100 μg/kg
Fat
300 μg/kg
Liver
200 μg/kg
Kidney
Rabbit
50 μg/kg
Muscle
100 μg/kg
Fat
300 μg/kg
Liver
200 μg/kg
Kidney
Poultry
50 μg/kg
Muscle
100 μg/kg
Fat
300 μg/kg
Liver
200 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2007/1064/annex/division/1/division/1.2/division/1.2.15 (the official version)
Page: https://openlegislation.uk/eu-regulation-2007-1064/annex/division-1/division-1.2/division-1.2.15
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.